Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

The intensive and prolonged immunosuppressive therapy required to prevent or treat graft-versus-host disease (GVHD) after allogeneic blood or marrow transplantation (alloBMT) puts patients at substantial risk for life-threatening infections, organ toxicity, and disease relapse. Posttransplantation c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Kanakry, Christopher G., Bolaños-Meade, Javier, Kasamon, Yvette L., Zahurak, Marianna, Durakovic, Nadira, Furlong, Terry, Mielcarek, Marco, Medeot, Marta, Gojo, Ivana, Smith, B. Douglas, Kanakry, Jennifer A., Borrello, Ivan M., Brodsky, Robert A., Gladstone, Douglas E., Huff, Carol Ann, Matsui, William H., Swinnen, Lode J., Cooke, Kenneth R., Ambinder, Richard F., Fuchs, Ephraim J., de Lima, Marcos J., Andersson, Borje S., Varadhan, Ravi, O’Donnell, Paul V., Jones, Richard J., Luznik, Leo
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2017
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345732/
https://ncbi.nlm.nih.gov/pubmed/28049637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-09-737825
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars